Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19

Since the rapidly evolving outbreak of COVID-19, several empirical therapeutic options have been recommended including the use of antivirals, steroids, and vaccines. According to recent observations about different modalities in treatment of patients infected with COVID-19, plasmapheresis and intrav...

Descripción completa

Detalles Bibliográficos
Autores principales: Pourahmad, Ramtin, Moazzami, Bobak, Rezaei, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392618/
https://www.ncbi.nlm.nih.gov/pubmed/32838178
http://dx.doi.org/10.1007/s42399-020-00438-2
_version_ 1783564881714216960
author Pourahmad, Ramtin
Moazzami, Bobak
Rezaei, Nima
author_facet Pourahmad, Ramtin
Moazzami, Bobak
Rezaei, Nima
author_sort Pourahmad, Ramtin
collection PubMed
description Since the rapidly evolving outbreak of COVID-19, several empirical therapeutic options have been recommended including the use of antivirals, steroids, and vaccines. According to recent observations about different modalities in treatment of patients infected with COVID-19, plasmapheresis and intravenous immunoglobulin (IVIg) have been reported to be an effective empirical therapeutic option to control the infection. In this review, we aimed to provide an overview on the possible application of plasmapheresis and intravenous immunoglobulin in patients with COVID-19.
format Online
Article
Text
id pubmed-7392618
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73926182020-07-31 Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19 Pourahmad, Ramtin Moazzami, Bobak Rezaei, Nima SN Compr Clin Med Covid-19 Since the rapidly evolving outbreak of COVID-19, several empirical therapeutic options have been recommended including the use of antivirals, steroids, and vaccines. According to recent observations about different modalities in treatment of patients infected with COVID-19, plasmapheresis and intravenous immunoglobulin (IVIg) have been reported to be an effective empirical therapeutic option to control the infection. In this review, we aimed to provide an overview on the possible application of plasmapheresis and intravenous immunoglobulin in patients with COVID-19. Springer International Publishing 2020-07-31 2020 /pmc/articles/PMC7392618/ /pubmed/32838178 http://dx.doi.org/10.1007/s42399-020-00438-2 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Covid-19
Pourahmad, Ramtin
Moazzami, Bobak
Rezaei, Nima
Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
title Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
title_full Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
title_fullStr Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
title_full_unstemmed Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
title_short Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
title_sort efficacy of plasmapheresis and immunoglobulin replacement therapy (ivig) on patients with covid-19
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392618/
https://www.ncbi.nlm.nih.gov/pubmed/32838178
http://dx.doi.org/10.1007/s42399-020-00438-2
work_keys_str_mv AT pourahmadramtin efficacyofplasmapheresisandimmunoglobulinreplacementtherapyivigonpatientswithcovid19
AT moazzamibobak efficacyofplasmapheresisandimmunoglobulinreplacementtherapyivigonpatientswithcovid19
AT rezaeinima efficacyofplasmapheresisandimmunoglobulinreplacementtherapyivigonpatientswithcovid19

Ejemplares similares